Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of Calgary

$745,876.00

Targeting brain cholesterol homeostasis to counteract prion diseases

EF 2019-20

Résumé
Many diseases of the brain are caused by proteins that change their three-dimensional shape, and as a consequence form 'clumps' or aggregates in brain cells, eventually destroying the brain. Prion diseases such as Creutzfeldt-Jakob disease are the prototype group for such disorders. They are always fatal and cannot be treated to date. We found that cholesterol, an important component of cellular membranes, is elevated in prion-infected neurons, which favors the aggregation of the disease-causing protein. We propose to elucidate the consequences of elevated cholesterol levels and use a re-purposed pharmaceutical as a new approach for treatment of prion diseases.
Programme
Project Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
419868
Name
Gilch Sabine
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cell Biology - Disease
Projecttitle
Targeting brain cholesterol homeostasis to counteract prion diseases
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$745,876
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cell Biology Of Prion Infection; Cholesterol Metabolism; Endocytic Vesicle Trafficking; Mouse Models Of Prion Disease; Neurodegeneration; Prion Disease; Treatment Of Prion Disease
Abstract
Many diseases of the brain are caused by proteins that change their three-dimensional shape, and as a consequence form 'clumps' or aggregates in brain cells, eventually destroying the brain. Prion diseases such as Creutzfeldt-Jakob disease are the prototype group for such disorders. They are always fatal and cannot be treated to date. We found that cholesterol, an important component of cellular membranes, is elevated in prion-infected neurons, which favors the aggregation of the disease-causing protein. We propose to elucidate the consequences of elevated cholesterol levels and use a re-purposed pharmaceutical as a new approach for treatment of prion diseases.
Competitiondate
202003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Gilch, Sabine
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $745,876~ $0~